Wuhan General Group (China), Inc./ US9825691051 /
02/02/2024 20:46:40 | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
0.0000USD | - | 1,200 Turnover: .0012 |
-Bid Size: - | -Ask Size: - | 0.0000 | 0.0000 |
GlobeNewswire
22/05/2020
CORRECTING and REPLACING – Jeff Robinson, CEO of Wuhan, Provides Key Updates and Outlook in a New Au...
GlobeNewswire
22/05/2020
Jeff Robinson, CEO of Wuhan, Provides Key Updates and Outlook in a New Audio Interview with SmallCap...
GlobeNewswire
29/04/2020
Acreage Provides Update on Timing of Filing of Financial Statements for 2019 and First Quarter 2020
GlobeNewswire
26/03/2020
Puyi Inc. Announces Unaudited Financial Results For the First Half of the Fiscal Year 2020
GlobeNewswire
10/03/2020
Chime Biologics Evolving Into One of the Leading CDMOs in China Serving the Global Biotech Industry
GlobeNewswire
24/01/2020
CORONAVIRUS: CHINA BROADENS REGIONAL LOCKDOWN AFTER MORE DEATHS AND CASES CONFIRMED IN 10 COUNTRIES
GlobeNewswire
15/08/2019
Wuhan General Group Appoints Distinguished Scientist Dr. Hyder A. Khoja as Chief Scientific Officer
GlobeNewswire
07/08/2019
Wuhan Announces Strategic Reorganization for Its Operational Advancement in the Medical Marijuana an...
GlobeNewswire
02/07/2019
Wuhan Provides Updates on Corporate, Psilocybin and Cannabis Q3 2019 Milestones
GlobeNewswire
30/01/2019
WUHAN AND BIODELTA FORM INTERNATIONAL JOINT VENTURE - To launch Dr. AnnaRx CBD Products in 1,000 Pha...
GlobeNewswire
14/09/2018
Wuhan General Group confirms the cancelation of 60% of its outstanding common shares
GlobeNewswire
11/09/2018
US Defense Department Facility to be Transformed into Cryptocurrency Mining Farm
GlobeNewswire
04/09/2018
Wuhan General Group Announces Intention to Spin-off Company's Tech Development Business
GlobeNewswire
29/08/2018
Wuhan General Group intent to cancel two-thirds of its outstanding common shares in 2018